A small proportion of patients with STEMI treated via primary PCI experienced late ventricular tachycardia (VT) or ventricular fibrillation (VF), occurring one or more days following the procedure, ...

PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to ...

Below-the-knee (BTK) arterial disease represents a significant challenge in peripheral artery disease (PAD) management, particularly in patients with chronic limb-threatening ischemia (CLTI). CLTI ...

An impressive 470 cardiovascular clinicians from across the U.S., took part in ACC's 2024 Legislative Conference in Washington, DC, from Sept. 29 to Oct. 1, where key issues like establishing ...

Get ready for the Great American Smokeout on Nov. 21. Click here to download this infographic from CardioSmart to support conversations with patients. In the U.S., smoking contributes to one-third of ...

New to this year's Summit, the Chest Pain Solution Room offered participants of the Chest Pain – MI Registry and Chest Pain Center Accreditation the opportunity to interact with each other in a ...

Supplying clinicians spanning the entire cardiovascular care team with the tools, resources and insights needed to design, lead and achieve the highest quality care at their institutions was the focus ...

Hospitals with lower risk-adjusted in-hospital mortality rates (RAMR) among patients with cardiogenic shock following acute myocardial infarction (AMI) demonstrated higher rates of revascularization ...

The idea that obesity increases the risk of heart failure seems like an obvious conclusion. After all, as the Framingham Heart Study clearly showed, obesity and overweight are significantly associated ...

The ACC is dedicated to developing and advancing solutions that will optimize the delivery of cardiovascular care, increase access to care, decrease health inequities in communities nationwide, and ...

Steroidal mineralocorticoid receptor antagonists (MRAs) lower mortality in patients with heart failure and reduced ejection fraction (HFrEF), but more data are needed about nonsteroidal MRAs like ...

The OPTIMAS trial showed that early initiation of a DOAC after acute ischemic stroke associated with atrial fibrillation is noninferior to late initiation of a DOAC. Patients with acute ischemic ...